MIRA Pharmaceuticals Stock (NASDAQ:MIRA)


FinancialsChart

Previous Close

$1.26

52W Range

$0.51 - $5.01

50D Avg

$1.34

200D Avg

$1.23

Market Cap

$21.47M

Avg Vol (3M)

$1.95M

Beta

6.73

Div Yield

-

MIRA Company Profile


MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Show More

Industry

Drug Manufacturers - General

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Aug 14, 2023

Website

MIRA Performance


MIRA Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD